A detailed history of Personal Cfo Solutions, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Personal Cfo Solutions, LLC holds 663 shares of VRTX stock, worth $333,124. This represents 0.05% of its overall portfolio holdings.

Number of Shares
663
Previous 665 0.3%
Holding current value
$333,124
Previous $277,000 11.91%
% of portfolio
0.05%
Previous 0.05%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$392.81 - $485.53 $785 - $971
-2 Reduced 0.3%
663 $310,000
Q1 2024

May 13, 2024

SELL
$407.69 - $446.08 $132,091 - $144,529
-324 Reduced 32.76%
665 $277,000
Q4 2023

Feb 13, 2024

SELL
$343.0 - $410.68 $25,382 - $30,390
-74 Reduced 6.96%
989 $402,000
Q3 2023

Nov 13, 2023

BUY
$338.18 - $362.46 $96,043 - $102,938
284 Added 36.46%
1,063 $369,000
Q2 2023

Aug 10, 2023

SELL
$314.42 - $351.91 $21,694 - $24,281
-69 Reduced 8.14%
779 $274,000
Q1 2023

May 09, 2023

SELL
$283.23 - $323.1 $28,889 - $32,956
-102 Reduced 10.74%
848 $267,000
Q4 2022

Feb 14, 2023

BUY
$285.76 - $321.48 $571 - $642
2 Added 0.21%
950 $274,000
Q3 2022

Nov 01, 2022

BUY
$273.83 - $305.53 $821 - $916
3 Added 0.32%
948 $274,000
Q2 2022

Aug 05, 2022

SELL
$234.96 - $292.55 $188,202 - $234,332
-801 Reduced 45.88%
945 $266,000
Q1 2022

May 02, 2022

BUY
$221.42 - $260.97 $182,007 - $214,517
822 Added 88.96%
1,746 $456,000
Q4 2021

Feb 11, 2022

BUY
$177.01 - $223.45 $163,557 - $206,467
924 New
924 $203,000
Q2 2021

Jul 22, 2021

SELL
$187.49 - $221.1 $251,611 - $296,716
-1,342 Closed
0 $0
Q1 2021

Apr 21, 2021

BUY
$207.02 - $241.31 $93,780 - $109,313
453 Added 50.96%
1,342 $288,000
Q4 2020

Feb 09, 2021

BUY
$207.01 - $276.09 $1,449 - $1,932
7 Added 0.79%
889 $210,000
Q3 2020

Nov 02, 2020

BUY
$255.65 - $303.1 $38,091 - $45,161
149 Added 20.33%
882 $0
Q2 2020

Aug 03, 2020

BUY
$225.48 - $295.8 $165,276 - $216,821
733 New
733 $213,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $129B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Personal Cfo Solutions, LLC Portfolio

Follow Personal Cfo Solutions, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Personal Cfo Solutions, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Personal Cfo Solutions, LLC with notifications on news.